Last Updated: Thursday, September 10, 2015, 16:03
FIPB will take up 25 foreign direct investment (FDI) proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors, on September 22.
Last Updated: Thursday, September 10, 2015, 08:04
"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.
Last Updated: Tuesday, September 1, 2015, 13:01
The company has started the integration of opiates business after completion of the deal, which would strengthen its position in global market and expand its narcotics raw material (NRM) market share.
Last Updated: Sunday, August 30, 2015, 13:28
Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.
Last Updated: Saturday, August 29, 2015, 20:22
Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today
Last Updated: Friday, August 28, 2015, 19:24
Sun Pharmaceutical Industries on Friday said a class action lawsuit has been filed against its US arm by some former employees following the shut down of a manufacturing unit at Detroit in Michigan.
Last Updated: Thursday, August 20, 2015, 11:22
Three Indian companies figure in Forbes` annual list of The World`s Most Innovative Companies topped by Tesla Motors, leading maker of fully electric vehicles.
Last Updated: Tuesday, August 11, 2015, 21:58
Sun Pharma had posted net profit after taxes and minority interest of Rs 1,204.59 crore for the April-June period of last fiscal, 2014-15.
Last Updated: Thursday, July 30, 2015, 20:47
India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.
Last Updated: Tuesday, July 21, 2015, 19:46
The broader 50-share NSE Nifty opened higher at 8,601.50 and fluctuated between a high of 8,646.75 and low of 8,517.90 before ending at 8,529.45, a sharp fall of 74 points, or 0.86 percent.
Last Updated: Tuesday, July 21, 2015, 19:10
Shares of Sun Pharma plunged 15 percent Tuesday, wiping out Rs 34,055.55 crore from its market valuation, after the drug major said it expects to take a hit on profit for the fiscal due to charges related to the ongoing integration with Ranbaxy Laboratories.
Last Updated: Tuesday, July 21, 2015, 09:42
Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.
more videos >>
